Drugs / Mercilon
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 31 trial | ||||||
| Phase 3 | NCT00236782 | Oct 1997 → Mar 1999 | — | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Completed | No outcome recorded |
| Comparator or background therapy1 trial | ||||||
| — | NCT00675779 Comparator | Apr 2008 → Nov 2010 | endometriosis | Poznan University of Medical Sciences | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | mercilon | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00236782 ↗ |
| Route | Oral | “Mercilon pill will be taken on the first day of menses” NCT00236782 ↗ |